19 information-science-"https:"-"https:"-"https:"-"https:"-"https:"-"https:"-"https:" positions at Amsterdam UMC
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
The POLARIS training network POLARIS is a European Marie Skłodowska-Curie Doctoral Network focused on accelerating therapy development for leukodystrophies: rare genetic disorders affecting
-
department is highly interdisciplinary with informatics researchers working closely together with practicing cardiologists to advance the use of AI for personalised treatment. The ultimate goal is to be able
-
The Neuropathology Research team is part of the department of Pathology at Amsterdam UMC. The team consists of neuroscientists and neuropathologists working on research into neurodegenerative
-
In this Postdoc position, you will investigate bone remodelling and fracture healing in a rare genetic bone disorder, Osteogenesis Imperfecta (OI), using a human-relevant organ-on-chip model. OI is
-
The cerebral vascular bed does more than supply blood to the brain. It also maintains the blood-brain barrier and helps remove waste products through the so-called glymphatic system. The glymphatic
-
Vrije Universiteit Brussel (VUB) is the recruiting organisation for this position. You will be employed by the Molecular Imaging and Therapy (MITH) research group and embedded in the POLARIS
-
sensitive to disruption of the RNA splicing machinery. The project combines molecular biology, cell biology and genomics with state-of-the-art technologies such as confocal microscopy and (single-cell) RNA
-
patient-informed treatment priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical
-
patient-informed treatment priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical
-
patient-informed treatment priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical